GPT and metabolic dysfunction-associated steatotic liver disease: These results suggest that the SC and MAN dual-labeled NaA liposomes effectively mitigate liver damage in NAFLD mice by lowering serum ALT and AST levels, demonstrating superior efficacy compared to NaA treatment alone.